Swiss National Bank Vertex Pharmaceuticals Inc Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

A detailed history of Swiss National Bank transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Swiss National Bank holds 766,000 shares of VRTX stock, worth $346 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
766,000
Previous 764,800 0.16%
Holding current value
$346 Million
Previous $358 Million 0.62%
% of portfolio
0.24%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$460.0 - $505.78 $552,000 - $606,936
1,200 Added 0.16%
766,000 $356 Million
Q2 2024

Aug 08, 2024
SELL
$392.81 - $485.53 $2.71 Million - $3.35 Million
-6,900 Reduced 0.89%
764,800 $358 Million
Q1 2024

May 07, 2024
SELL
$407.69 - $446.08 $14.4 Million - $15.8 Million
-35,400 Reduced 4.39%
771,700 $323 Million
Q4 2023

Feb 06, 2024
SELL
$343.0 - $410.68 $7.31 Million - $8.75 Million
-21,300 Reduced 2.57%
807,100 $328 Million
Q3 2023

Nov 08, 2023
SELL
$338.18 - $362.46 $34.5 Million - $36.9 Million
-101,900 Reduced 10.95%
828,400 $288 Million
Q2 2023

Aug 09, 2023
SELL
$314.42 - $351.91 $27.8 Million - $31.1 Million
-88,500 Reduced 8.69%
930,300 $327 Million
Q1 2023

May 10, 2023
SELL
$283.23 - $323.1 $6.68 Million - $7.63 Million
-23,600 Reduced 2.26%
1,018,800 $321 Million
Q4 2022

Feb 08, 2023
SELL
$285.76 - $321.48 $18.9 Million - $21.2 Million
-65,975 Reduced 5.95%
1,042,400 $301 Million
Q3 2022

Nov 09, 2022
BUY
$273.83 - $305.53 $1.12 Million - $1.25 Million
4,100 Added 0.37%
1,108,375 $321 Million
Q2 2022

Aug 09, 2022
BUY
$234.96 - $292.55 $728,376 - $906,905
3,100 Added 0.28%
1,104,275 $311 Million
Q1 2022

May 09, 2022
BUY
$221.42 - $260.97 $25.5 Million - $30 Million
115,100 Added 11.67%
1,101,175 $287 Million
Q4 2021

Feb 08, 2022
SELL
$177.01 - $223.45 $6.66 Million - $8.4 Million
-37,600 Reduced 3.67%
986,075 $217 Million
Q3 2021

Nov 08, 2021
SELL
$181.39 - $202.99 $6.58 Million - $7.37 Million
-36,300 Reduced 3.42%
1,023,675 $186 Million
Q2 2021

Aug 06, 2021
SELL
$187.49 - $221.1 $80.4 Million - $94.9 Million
-429,000 Reduced 28.81%
1,059,975 $214 Million
Q1 2021

May 07, 2021
BUY
$207.02 - $241.31 $4.45 Million - $5.19 Million
21,500 Added 1.47%
1,488,975 $320 Million
Q4 2020

Feb 05, 2021
BUY
$207.01 - $276.09 $16 Million - $21.3 Million
77,300 Added 5.56%
1,467,475 $347 Million
Q3 2020

Nov 09, 2020
BUY
$255.65 - $303.1 $52.3 Million - $62 Million
204,400 Added 17.24%
1,390,175 $378 Million
Q2 2020

Aug 05, 2020
BUY
$225.48 - $295.8 $33.8 Million - $44.3 Million
149,700 Added 14.45%
1,185,775 $344 Million
Q1 2020

May 08, 2020
BUY
$199.77 - $247.81 $41.1 Million - $51 Million
205,900 Added 24.8%
1,036,075 $247 Million
Q4 2019

Feb 06, 2020
SELL
$166.71 - $223.91 $5.8 Million - $7.79 Million
-34,800 Reduced 4.02%
830,175 $182 Million
Q3 2019

Nov 12, 2019
BUY
$166.23 - $187.09 $1.81 Million - $2.03 Million
10,866 Added 1.27%
864,975 $147 Million
Q2 2019

Aug 02, 2019
BUY
$164.61 - $190.37 $197,532 - $228,444
1,200 Added 0.14%
854,109 $157 Million
Q1 2019

May 10, 2019
BUY
$163.73 - $194.7 $3.6 Million - $4.28 Million
22,000 Added 2.65%
852,909 $157 Million
Q4 2018

Feb 13, 2019
BUY
$151.91 - $192.21 $2.64 Million - $3.34 Million
17,400 Added 2.14%
830,909 $138 Million
Q3 2018

Nov 08, 2018
SELL
$167.73 - $192.74 $4.24 Million - $4.88 Million
-25,300 Reduced 3.02%
813,509 $157 Million
Q2 2018

Aug 09, 2018
BUY
$145.72 - $169.96 $3.99 Million - $4.66 Million
27,400 Added 3.38%
838,809 $143 Million
Q1 2018

May 04, 2018
SELL
$151.6 - $177.13 $17.8 Million - $20.8 Million
-117,600 Reduced 12.66%
811,409 $132 Million
Q4 2017

Feb 07, 2018
BUY
$137.28 - $155.55 $1.48 Million - $1.68 Million
10,800 Added 1.18%
929,009 $139 Million
Q3 2017

Nov 03, 2017
BUY
$148.13 - $162.24 $136 Million - $149 Million
918,209
918,209 $140 Million

Others Institutions Holding VRTX

# of Institutions
1,721
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email